文献速递针灸推拿中医内科

穴位自血疗法成功治疗顽固性特应性湿疹:一例病例报告及机制假说

Successfully treated recalcitrant atopic eczema with acupoint autohemotherapy: A case report and hypothesized mechanism of the therapy.
PubMed 文献 · J Integr Med · 2022-01-13

本文报告一例26岁女性顽固性特应性湿疹患者,接受双侧足三里(ST36)与血海(SP10)穴位自血疗法,第一月每周一次、随后三个月每两周一次,疗程结束时症状完全消退,六个月随访期内免疫球蛋白E恢复正常且无复发;作者据此提出局部炎症触发局部及全身免疫反应导致抗炎与免疫调节的机制假说,并认为该疗法可作为其他治疗失败病例的有效补充治疗。

要点

  • 穴位自血疗法用于顽固性特应性湿疹可能有效,尤其其他治疗失败时。
  • 本例采用双侧足三里与血海,第一月每周一次、后每两周一次共三个月。
  • 疗程结束时症状完全消退,六个月随访免疫球蛋白E正常且无复发。

核心结论

  • 穴位自血疗法可能作为顽固性特应性湿疹的有效补充治疗,尤其适用于其他治疗失败的病例。
  • 作者假说反复治疗诱导的局部炎症反应触发局部免疫反应,进而引发全身免疫反应,最终产生抗炎与免疫调节效应。

研究设计与样本

  • 病例报告:一例26岁女性顽固性特应性湿疹患者,病程五年,接受双侧足三里(ST36)与血海(SP10)穴位自血疗法。

主要发现

  • 治疗频率为第一月每周一次,随后三个月每两周一次。
  • 疗程结束时患者特应性湿疹症状完全消退。
  • 六个月随访结束时免疫球蛋白E水平恢复至正常范围,随访期内无复发。

临床怎么用

  • 对于其他治疗失败的顽固性特应性湿疹,可考虑将穴位自血疗法作为补充治疗选项。
  • 本例选穴为双侧足三里与血海,疗程安排为第一月每周一次、随后三个月每两周一次。

局限性

  • 为单例病例报告,结论需进一步对照研究证实该疗法的价值与机制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Acupoint autohemotherapy at bilateral Zusanli (ST36) and Xuehai (SP10) was used to treat a 26-year-old female patient who had suffered from recalcitrant atopic eczema (AE) for five years. The treatment was applied at a frequency of once per week for the first month, followed by a three-month period of once every other week. At the end of treatment, the patient's AE symptoms were entirely resolved, and by the end of a six-month follow-up her immunoglobulin E level had returned to the normal range. Further, there was no relapse of AE symptoms during the six-month follow-up. Therefore, we hypothesized that after the repeated treatments the local inflammatory reaction induced by autologous blood injection triggered a local immune response, followed by a systemic immune response after the repeated treatment, finally leading to the anti-inflammation and immunomodulation effects. This case suggests that acupoint autohemotherapy could be used as an effective complementary treatment for recalcitrant AE, especially in cases where other treatments have failed. Further comparative studies are needed to corroborate the value and mechanisms of this therapy.

来源:J Integr Med,查看原文。版权归原作者所有。

引用

  1. Zhao B, Chen Y, Liao SM, et al. Successfully treated recalcitrant atopic eczema with acupoint autohemotherapy: A case report and hypothesized mechanism of the therapy. J Integr Med. 2022. PMID: 35101370. doi:10.1016/j.joim.2022.01.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。